Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plix is a rapidly growing plant-based nutrition and wellness company, offering a broad range of vegan, non-GMO, and toxin-free products—including effervescent tablets, gummies, peanut butter, capsules, and superfood powders—designed to make plant-based nutrition accessible, enjoyable, and convenient for health-conscious consumers. Their products are marketed as food supplements and wellness aids, not as regulated pharmaceutical therapies, and are available direct-to-consumer and through retail channels. Plix has expanded into skincare, haircare, and women’s health (PCOD/PCOS, intimate care), and has gained significant market traction in India, with recent expansion into the US and UAE. The company was acquired by Marico in July 2023, and its FY 2023-2024 revenue was ₹156 crores ($18.7 million), with a target of ₹500 crore ($60 million) by end of 2024. Plix differentiates itself through innovative formats, influencer marketing, and a commitment to clean-label, sustainable practices[1][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plix The Plant Fix.